Abliva Competitors and Similar CompaniesClear all

Abliva's competitors and similar companies include Molecular Partners and Prevail Therapeutics.

	Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.	Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases.	Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
Founding Date	Founding Date 2000	Founding Date 2004	Founding Date 2017
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma therapy	Tags Healthcare biotech clinical research drug development pharma therapy
Locations	Locations Lund, SE HQ	Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US	Locations New York, US HQ
Employees	Employees 950% increase	Employees 158	Employees 489% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr497k (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income (kr90m) (FY, 2024)	Net income (CHF61.7m) (FY, 2025)	Net income ($63.2m) (FY, 2019)
Funding
Total funding raised	Total funding raised $ 10.8m	Total funding raised N/A	Total funding raised $ 125m